Caloxin 2A1 (TFA)

Caloxin 2A1 (TFA) is a specialized peptide inhibitor recognized for its selective action against plasma membrane calcium ATPase (PMCA) isoforms. This compound is a valuable research tool due to its ability to modulate calcium extrusion from cells, thereby influencing a wide range of physiological and pathophysiological processes. Caloxin 2A1 (TFA) is synthesized to ensure high stability in aqueous environments, making it suitable for diverse experimental conditions in both in vitro and ex vivo studies. Its unique sequence and TFA salt form enhance solubility, allowing for straightforward integration into various assay systems. Researchers rely on this peptide for its specificity and reproducibility in targeting PMCA, which is essential for dissecting the intricate roles of calcium signaling in cellular function.

Calcium Transport Research: Caloxin 2A1 (TFA) is extensively employed in the study of calcium transport mechanisms across cellular membranes. By selectively inhibiting PMCA, it enables researchers to isolate and analyze the contribution of this transporter to overall calcium homeostasis. Through controlled application in cell cultures or isolated tissue systems, scientists can observe alterations in intracellular calcium dynamics, thereby elucidating the mechanisms by which cells maintain calcium equilibrium. This application is particularly relevant in understanding calcium-dependent signaling pathways and the regulation of cellular excitability in various cell types.

Neurobiology Studies: In neurobiology, Caloxin 2A1 (TFA) serves as a crucial tool for investigating the role of PMCA in neuronal calcium regulation. Neurons rely on tightly controlled calcium gradients for neurotransmitter release, synaptic plasticity, and excitability. By applying this peptide inhibitor, researchers can assess the impact of impaired calcium extrusion on neuronal signaling and plasticity. Such studies are instrumental in advancing knowledge of synaptic physiology, neuronal adaptation, and the molecular underpinnings of neurodegenerative processes associated with disrupted calcium handling.

Muscle Physiology Research: The use of Caloxin 2A1 (TFA) extends to muscle physiology, where calcium cycling is fundamental to contraction and relaxation dynamics. By modulating PMCA activity in muscle cells, investigators can dissect the specific contributions of this transporter to muscle function. This is particularly valuable in studies focused on skeletal, cardiac, and smooth muscle tissues, as it allows for the differentiation between various calcium handling pathways. Insights gained from these experiments inform the broader understanding of muscle fatigue, contractility, and adaptation under physiological and pathological conditions.

Cellular Signaling Pathway Analysis: Caloxin 2A1 (TFA) is instrumental in dissecting complex cellular signaling networks that depend on calcium fluxes. Its application in cell lines or primary cells permits the targeted disruption of PMCA-mediated calcium removal, thereby altering downstream signaling events. Researchers utilize this approach to map the cascade of molecular responses triggered by sustained intracellular calcium elevations, including gene expression, metabolic regulation, and cell fate decisions. This targeted inhibition is crucial for distinguishing PMCA-specific effects from those mediated by other calcium transporters or channels.

Pharmacological Screening: In the context of drug discovery and pharmacological research, Caloxin 2A1 (TFA) is used to evaluate the specificity and efficacy of novel compounds targeting calcium transport systems. By serving as a reference inhibitor for PMCA, it provides a benchmark for comparing the activity of new molecules or therapeutic candidates. This application enables the identification of selective modulators and helps delineate off-target effects, thereby facilitating the development of more precise pharmacological agents aimed at modulating calcium homeostasis.

Endocrine System Investigations: Beyond its established roles, Caloxin 2A1 (TFA) finds application in studies of hormone-secreting cells, where calcium signaling orchestrates secretion dynamics. Researchers employ this inhibitor to probe the regulatory mechanisms by which PMCA influences hormone release, cellular responsiveness, and adaptation to fluctuating extracellular signals. These investigations contribute to a deeper understanding of endocrine physiology and the interplay between calcium transport and hormone action, providing foundational insights for future research in cellular endocrinology.

1. Relatedness of antibodies to peptides containing homocitrulline or citrulline in patients with rheumatoid arthritis

2. C-Peptide replacement therapy and sensory nerve function in type 1 diabetic neuropathy

3. Investigating Potential Interactions Between Neurohypophyseal Peptides, their Drug Analogs, and Coagulation Factor VIII

4. Emerging applications of nanotechnology for diagnosis and therapy of disease: a review

5. Tachykinin-related peptides modulate immune-gene expression in the mealworm beetle Tenebrio molitor L